Tides USA – Oligonucleotide & Peptide Therapeutics, May 14-17, 2024, Boston, USA
We are excited to be exhibiting at Tides USA, taking place May 14-17, 2024 in Boston, USA.
ReciBioPharm combines the capabilities of CDMOs Arranta Bio, GenIbet, and Vibalogics as a trusted partner for biologics drug development and manufacturing services.
With our expanded portfolio of cutting-edge technologies and expertise, we offer a comprehensive suite of solutions to accelerate the production of complex therapeutics such as plasmid DNA, RNA-based therapies, viral-based vaccines, and microbiome live biotherapeutics.
Innovation is at the heart of ReciBioPharm, exploring uncharted territories in drug development. By forging strategic partnerships with leading biotech companies, we accelerate the translation of scientific discoveries into tangible clinical solutions.
Every breakthrough, drug candidate, and therapeutic innovation we help develop is driven by a commitment to improving human health. We aim to transform the lives of patients worldwide and drive meaningful impact across the healthcare landscape.
Meet us on site to discover first-hand how we are shaping the future of medicine and empowering healthcare providers with ground-breaking therapies that revolutionise the way we approach drug development.